ZBP1 Activators represent a unique and intriguing class of chemicals that have gained significant attention in the field of molecular biology and biochemistry due to their distinct mode of action and interaction with the Z-DNA binding protein 1 (ZBP1), also known as DAI (DNA-dependent activator of IFN-regulatory factors). ZBP1 is a pivotal protein involved in the intricate mechanisms of cellular response, specifically recognized for its role in the sensing of Z-form DNA and RNA. This class of activators is characterized by their ability to modulate the activity of ZBP1, thereby influencing the biochemical pathways associated with this protein.
The structure of ZBP1 Activators is diverse, often comprising small molecules with specific functional groups that enable them to interact effectively with the ZBP1 protein. This interaction is key to their mode of action, as it influences the conformation and, consequently, the activity of ZBP1. The binding of these activators to ZBP1 is believed to affect the protein's affinity for Z-DNA and Z-RNA, a unique form of nucleic acid structure. This interaction can lead to changes in the way ZBP1 engages with these nucleic acids, potentially altering the downstream processes in which ZBP1 is involved. These processes can include various cellular responses, highlighting the role of ZBP1 as a mediator in cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $198.00 | ||
A synthetic double-stranded RNA mimetic that can mimic viral infection, potentially enhancing ZBP1-mediated antiviral signaling. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A selective TLR7 agonist that can activate innate immune responses, possibly influencing pathways involving ZBP1. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
A TLR7 agonist known to stimulate the immune system, potentially enhancing ZBP1 activity in response to viral mimetics. | ||||||
2′,3′-cGAMP | 1441190-66-4 | sc-507484 | 10 mg | $1800.00 | ||
A STING agonist that activates innate immunity against DNA viruses, potentially influencing ZBP1 activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-κB inhibitor that could indirectly affect ZBP1 by modulating inflammatory signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
A JNK and p38 MAPK activator that could influence ZBP1 activity by affecting stress response pathways. | ||||||
MCC950 sodium salt | 256373-96-3 | sc-505904 sc-505904A sc-505904B sc-505904C | 5 mg 10 mg 50 mg 100 mg | $114.00 $198.00 $888.00 $1569.00 | 3 | |
Though an inhibitor of NLRP3, it may indirectly affect ZBP1 activity through modulation of inflammasome signaling. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
A JAK inhibitor that can modulate cytokine signaling, potentially affecting ZBP1 activity indirectly. | ||||||